Relapse of Legionnaires' disease in a renal transplant recipient

K. L. Sanders, David Walker, T. J. Lee

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The authors describe a 44-year-old man who recently recieved a cadaveric renal transplant and had a relapse of Legionnaires' disease after an appropriate course of therapy. The relapse occurred within two weeks after completion of a three-week course of therapy with erythromycin stearate. A transbronchial biopsy specimen was positive for Legionella pneumophila by direct immunofluorescence, although the Dieterie silver impregnation stain was negative. The patient responded to a repeated course of erythromycin for an additional 21 days, and no further sequelae or relapses have been noted. The importance of early rapid diagnostic modalities in the immunocompromised patient is emphasized, and the need to consider the possibility of relapse after effective therapy is warranted.

Original languageEnglish (US)
Pages (from-to)833-834
Number of pages2
JournalArchives of Internal Medicine
Volume140
Issue number6
DOIs
StatePublished - 1980
Externally publishedYes

Fingerprint

Legionnaires' Disease
Kidney
Recurrence
Legionella pneumophila
Direct Fluorescent Antibody Technique
Immunocompromised Host
Erythromycin
Silver
Coloring Agents
Therapeutics
Transplants
Biopsy
Transplant Recipients

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Relapse of Legionnaires' disease in a renal transplant recipient. / Sanders, K. L.; Walker, David; Lee, T. J.

In: Archives of Internal Medicine, Vol. 140, No. 6, 1980, p. 833-834.

Research output: Contribution to journalArticle

Sanders, K. L. ; Walker, David ; Lee, T. J. / Relapse of Legionnaires' disease in a renal transplant recipient. In: Archives of Internal Medicine. 1980 ; Vol. 140, No. 6. pp. 833-834.
@article{ec4333b8b2f248d0935387693e355675,
title = "Relapse of Legionnaires' disease in a renal transplant recipient",
abstract = "The authors describe a 44-year-old man who recently recieved a cadaveric renal transplant and had a relapse of Legionnaires' disease after an appropriate course of therapy. The relapse occurred within two weeks after completion of a three-week course of therapy with erythromycin stearate. A transbronchial biopsy specimen was positive for Legionella pneumophila by direct immunofluorescence, although the Dieterie silver impregnation stain was negative. The patient responded to a repeated course of erythromycin for an additional 21 days, and no further sequelae or relapses have been noted. The importance of early rapid diagnostic modalities in the immunocompromised patient is emphasized, and the need to consider the possibility of relapse after effective therapy is warranted.",
author = "Sanders, {K. L.} and David Walker and Lee, {T. J.}",
year = "1980",
doi = "10.1001/archinte.140.6.833",
language = "English (US)",
volume = "140",
pages = "833--834",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "6",

}

TY - JOUR

T1 - Relapse of Legionnaires' disease in a renal transplant recipient

AU - Sanders, K. L.

AU - Walker, David

AU - Lee, T. J.

PY - 1980

Y1 - 1980

N2 - The authors describe a 44-year-old man who recently recieved a cadaveric renal transplant and had a relapse of Legionnaires' disease after an appropriate course of therapy. The relapse occurred within two weeks after completion of a three-week course of therapy with erythromycin stearate. A transbronchial biopsy specimen was positive for Legionella pneumophila by direct immunofluorescence, although the Dieterie silver impregnation stain was negative. The patient responded to a repeated course of erythromycin for an additional 21 days, and no further sequelae or relapses have been noted. The importance of early rapid diagnostic modalities in the immunocompromised patient is emphasized, and the need to consider the possibility of relapse after effective therapy is warranted.

AB - The authors describe a 44-year-old man who recently recieved a cadaveric renal transplant and had a relapse of Legionnaires' disease after an appropriate course of therapy. The relapse occurred within two weeks after completion of a three-week course of therapy with erythromycin stearate. A transbronchial biopsy specimen was positive for Legionella pneumophila by direct immunofluorescence, although the Dieterie silver impregnation stain was negative. The patient responded to a repeated course of erythromycin for an additional 21 days, and no further sequelae or relapses have been noted. The importance of early rapid diagnostic modalities in the immunocompromised patient is emphasized, and the need to consider the possibility of relapse after effective therapy is warranted.

UR - http://www.scopus.com/inward/record.url?scp=0018885206&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018885206&partnerID=8YFLogxK

U2 - 10.1001/archinte.140.6.833

DO - 10.1001/archinte.140.6.833

M3 - Article

VL - 140

SP - 833

EP - 834

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 6

ER -